Collaborative Counseling Considerations for Pharmacogenomic Tests

Increased use of pharmacogenomic (PGx) testing in the clinical setting has revealed a number of challenges to providing this service. PGx is an important component of precision medicine that brings together the fields of genetics and clinical pharmacology. A model that incorporates a multidisciplina...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacotherapy 2017-09, Vol.37 (9), p.990-999
Main Authors: Zierhut, Heather A., Campbell, Colleen A., Mitchell, Allison G., Lemke, Amy A., Mills, Rachel, Bishop, Jeffrey R.
Format: Article
Language:English
Subjects:
Children
disease associations
Genetic counseling
Genetic Counseling - methods
Genetic Counseling - trends
Genetic Testing - methods
Genetic Testing - trends
Genetics
Humans
Intersectoral Collaboration
Partnerships
Patient Education as Topic - methods
Patient Education as Topic - trends
Pharmacists
pharmacogenetics
Pharmacogenetics - methods
Pharmacogenetics - trends
Pharmacogenomics
Pharmacology
Precision medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Increased use of pharmacogenomic (PGx) testing in the clinical setting has revealed a number of challenges to providing this service. PGx is an important component of precision medicine that brings together the fields of genetics and clinical pharmacology. A model that incorporates a multidisciplinary approach to implementation and information delivery may be the most beneficial to patients and providers. In this review, translational considerations in the provision of PGx testing and counseling services are described. Specifically, we report on the selection of PGx tests, the provision of patient education and counseling, and examples of PGx service delivery models that incorporate counseling by pharmacists and genetic counselors. Examples of ancillary risks associated with PGx testing, testing of children, and familial implications of testing are reviewed. Through multispecialty partnerships, including genetic counselors and pharmacists, implementation obstacles to PGx testing can be overcome to provide quality precision medicine to patients.
ISSN:0277-0008
1875-9114
DOI:10.1002/phar.1980